World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
43606
World Ranking
10693
National Ranking
5496

Tito Fojo publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Tito Fojo sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 308 publications — 18th percentile

18% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Tito Fojo D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Tito Fojo sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 93 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Tito Fojo is affiliated with Columbia University in the United States and has a research focus primarily within the field of medicine, with particular emphasis on oncology. Their extensive publication record reflects contributions to oncology, pulmonary and respiratory medicine, cancer research, radiology, nuclear medicine and imaging, and surgery.

Their research emphasis covers a variety of main topics including:

  • Cancer Genomics and Diagnostics
  • Radiomics and Machine Learning in Medical Imaging
  • Adrenal and Paraganglionic Tumors
  • Cancer, Hypoxia, and Metabolism
  • Colorectal Cancer Treatments and Studies
  • Prostate Cancer Treatment and Research
  • Neuroblastoma Research and Treatments

Some recent papers authored or co-authored by Tito Fojo include:

  • "Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy Using a Novel Imaging Analysis," 2022, JAMA Oncology
  • "Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement," 2023, Nature Reviews Endocrinology
  • "Emerging Therapeutic Implications of STK11 Mutation: Case Series," 2020, The Oncologist
  • "Enhanced Detection of Treatment Effects on Metastatic Colorectal Cancer with Volumetric CT Measurements for Tumor Burden Growth Rate Evaluation," 2020, Clinical Cancer Research
  • "Inappropriate censoring in Kaplan-Meier analyses," 2021, The Lancet Oncology

Frequently appearing publication venues for their work include:

  • The Oncologist
  • Seminars in Oncology
  • Journal of Clinical Oncology
  • The Lancet Oncology
  • JAMA Network Open

Tito Fojo has collaborated often with several co-authors, including:

  • Susan E. Bates
  • Mengxi Zhou
  • Lawrence H. Schwartz
  • Laurent Dercle
  • Binsheng Zhao

Best Publications

  • Multidrug resistance in cancer: role of ATP–dependent transporters

    Michael M. Gottesman;Tito Fojo;Susan E. Bates

  • Tumour stem cells and drug resistance

    Michael Dean;Tito Fojo;Susan Bates

  • An Information-Intensive Approach to the Molecular Pharmacology of Cancer

    John N. Weinstein;Timothy G. Myers;Patrick M. O'Connor;Stephen H. Friend

  • The Role of ABC Transporters in Clinical Practice

    Gregory D. Leonard;Tito Fojo;Susan E. Bates

  • Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.

    Keisuke Miyake;Lyn Mickley;Thomas Litman;Zhirong Zhan

  • Paclitaxel-resistant Human Ovarian Cancer Cells Have Mutant β-Tubulins That Exhibit Impaired Paclitaxel-driven Polymerization

    Paraskevi Giannakakou;Dan L. Sackett;Yoon-Koo Kang;Zhirong Zhan

  • Combination Chemotherapy in Advanced Adrenocortical Carcinoma

    Martin Fassnacht;Massimo Terzolo;Bruno Allolio;Eric Baudin

  • Oxaliplatin, Tetraplatin, Cisplatin, and Carboplatin: Spectrum of Activity in Drug-Resistant Cell Lines and in the Cell Lines of the National Cancer Institute's Anticancer Drug Screen Panel

    Olivier Rixe;Waldo Ortuzar;Manuel Alvarez;Ricardo Parker

  • Delivering affordable cancer care in high-income countries

    Richard Sullivan;Jeffrey Peppercorn;Karol Sikora;John Zalcberg

  • A common pharmacophore for epothilone and taxanes: Molecular basis for drug resistance conferred by tubulin mutations in human cancer cells

    Paraskevi Giannakakou;Rick Gussio;Eva Nogales;Kenneth H. Downing

  • Raf-1/bcl-2 Phosphorylation: A Step from Microtubule Damage to Cell Death

    Mikhail V. Blagosklonny;Paraskevi Giannakakou;Wafik S. El-Deiry;David G. I. Kingston

  • Microtubule-interfering Agents Activate c-Jun N-terminal Kinase/Stress-activated Protein Kinase through Both Ras and Apoptosis Signal-regulating Kinase Pathways

    Tzu Hao Wang;Hsin Shih Wang;Hidenori Ichijo;Paraskevi Giannakakou

  • Strategies for reversing drug resistance.

    Tito Fojo;Susan Bates

  • Molecular effects of paclitaxel: myths and reality (a critical review).

    Mikhail V. Blagosklonny;Tito Fojo

  • p53 is associated with cellular microtubules and is transported to the nucleus by dynein.

    Paraskevi Giannakakou;Dan L. Sackett;Yvona Ward;Kevin R. Webster

  • How Much Is Life Worth: Cetuximab, Non–Small Cell Lung Cancer, and the $440 Billion Question

    Tito Fojo;Christine Grady

  • Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia

    Zhengping Zhuang;Chunzhang Yang;Felipe Lorenzo;Maria Merino

  • p53 Inhibits Hypoxia-inducible Factor-stimulated Transcription *

    Mikhail V. Blagosklonny;Won G. An;Larisa Y. Romanova;Jane Trepel

  • Cancer Drugs in the United States: Justum Pretium—The Just Price

    Hagop M. Kantarjian;Tito Fojo;Michael Mathisen;Leonard A. Zwelling

  • Unintended consequences of expensive cancer therapeutics—the pursuit of marginal indications and a me-too mentality that stifles innovation and creativity: the John Conley Lecture.

    Tito Fojo;Sham Mailankody;Andrew Lo

Frequent Co-Authors

Susan E. Bates
Susan E. Bates Columbia University
Mikhail V. Blagosklonny
Mikhail V. Blagosklonny Roswell Park Cancer Institute
Seth M. Steinberg
Seth M. Steinberg National Institutes of Health
William D. Figg
William D. Figg National Institutes of Health
Karel Pacak
Karel Pacak National Institutes of Health
Wilfred D. Stein
Wilfred D. Stein Hebrew University of Jerusalem
Frank M. Balis
Frank M. Balis Children's Hospital of Philadelphia
Peter L. Choyke
Peter L. Choyke National Institutes of Health
Thomas Litman
Thomas Litman University of Copenhagen
Maria J. Merino
Maria J. Merino National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring ways to enter or advance in healthcare without attending traditional, on-campus programs, there are many flexible online options. Many prospective students start their medical journey with online nursing courses. These provide foundational knowledge and clinical skills, often at lower costs and with greater scheduling flexibility.

For registered nurses seeking career growth, the cheapest rn to bsn program options can help you earn your Bachelor of Science in Nursing online and efficiently. Those interested in leadership, research, or academia may consider online nursing phd programs, which offer advanced education and open doors to policy or faculty roles.

Non-nursing majors looking for a rapid career change can benefit from online direct entry msn programs for non-nursing majors. These programs enable swift entry into advanced nursing careers, even without a prior nursing background.

Pursuing online degrees in healthcare can provide a flexible and affordable pathway into rewarding medical and nursing professions in the USA.

Best Scientists Citing Tito Fojo

Trending Scientists

Recently Published Articles